financetom
Business
financetom
/
Business
/
Is Disney Stock A Buy After Josh D'Amaro Takes Over As CEO?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Is Disney Stock A Buy After Josh D'Amaro Takes Over As CEO?
Mar 19, 2026 8:04 AM

Walt Disney Co ( DIS ) shares are trading slightly higher Thursday morning as investors weigh a major leadership transition and Wall Street's view that the media giant may have fresh upside under new CEO Josh D'Amaro.

D'Amaro officially succeeded Bob Iger this week, ending Iger's second stint in the top role and opening a new chapter for the entertainment company. Here’s what investors need to know.

Disney ( DIS ) stock is trending Thursday. Where is DIS stock headed?

Guggenheim Sees Path To Higher Investor Confidence

Analysts see opportunity in Disney's ( DIS ) unmatched portfolio of franchises, including Marvel and Star Wars, and believe D'Amaro's leadership could help sharpen execution across content, streaming and theme parks.

Guggenheim analyst Michael Morris said Disney ( DIS ) can improve investor confidence by delivering a steadier cadence of high-quality content, increasing transparency in its streaming and entertainment businesses, and optimizing its parks and resorts division, where D'Amaro has deep experience.

The CEO handoff also has investors revisiting Disney's ( DIS ) uneven stock history under Iger. During his first run as CEO, Disney ( DIS ) delivered a 457.6% return, excluding dividends, but shares were roughly flat during his second term from late 2022 through March 17, 2026.

Disney ( DIS ) stock is also down 10.5% year to date in 2026, underscoring the pressure on D'Amaro to reignite growth.

Disney RSI Stays in Neutral Range Over The Past Year

Disney's ( DIS ) RSI has mostly hovered in the neutral range (30–70) over the past year, with occasional spikes into overbought territory above 70 and brief dips near oversold levels around 30.

Recently, the RSI appears to be trending toward the lower end of neutral, suggesting softer momentum without signaling deeply oversold conditions.

Disney ( DIS ) Analyst Consensus And Recent Price Target Changes

Analyst Consensus & Recent Actions: The stock carries a Buy Rating with an average price target of $131.71. Recent analyst moves include:

Guggenheim: Buy (Lowers Target to $115.00) (Mar. 18)

Guggenheim: Buy (Maintains Target to $140.00) (Feb. 3)

TD Cowen: Hold (Maintains Target to $123.00) (Feb. 3)

DIS Shares Edge Higher Thursday

DIS Price Action: Walt Disney ( DIS ) shares were up 0.18% at $99.60 at the time of publication on Thursday, according to Benzinga Pro data.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Equitable Q2 Non-GAAP Earnings, Revenue Fall; Shares Drop After Hours
Equitable Q2 Non-GAAP Earnings, Revenue Fall; Shares Drop After Hours
Aug 5, 2025
04:42 PM EDT, 08/05/2025 (MT Newswires) -- Equitable Holdings ( EQH ) reported Q2 non-GAAP earnings late Tuesday of $1.10 per diluted share, down from $1.43 a year earlier. Analysts polled by FactSet expected $1.28. Revenue in the three months ended June 30 fell to $2.36 billion from $3.51 billion a year earlier. Four analysts surveyed by FactSet expected $3.22...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Halozyme Therapeutics Q2 Non-GAAP Earnings, Revenue Increase; 2025 Guidance Raised
Halozyme Therapeutics Q2 Non-GAAP Earnings, Revenue Increase; 2025 Guidance Raised
Aug 5, 2025
04:43 PM EDT, 08/05/2025 (MT Newswires) -- Halozyme Therapeutics ( HALO ) reported Q2 non-GAAP earnings late Tuesday of $1.54 per diluted share, up from $0.91 a year earlier. Analysts polled by FactSet expected $1.24. Revenue for the quarter ended June 30 was $325.7 million, up from $231.4 million a year earlier. Analysts expected $285.9 million. For 2025, the biopharmaceutical...
Stonex Group Q3 net operating revenues rise 4% to $488.3 mln
Stonex Group Q3 net operating revenues rise 4% to $488.3 mln
Aug 5, 2025
Overview * Stonex ( SNEX ) fiscal Q3 net operating revenues rise 4% yr/yr to $488.3 mln * Net income for fiscal Q3 increases to $63.4 mln despite acquisition charges * Co completes acquisitions of R.J. O'Brien and The Benchmark Company, LLC Outlook * Company did not provide specific forward-looking guidance for future quarters * StoneX ( SNEX ) expects...
Copyright 2023-2026 - www.financetom.com All Rights Reserved